SLC2A1 and cardiovascular disorder: As Glut1 mRNA levels in atherosclerotic plaques predict accumulation of 18fluorodeoxyglucose [41], our results suggest that Glut1+ intermediate monocytes may be important mediators of cardiovascular disease.